Comparison between Citichem India IPO and Identical Brains Studios IPO.
Citichem India IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Identical Brains Studios IPO is a SME Bookbuilding proposed to list at NSE SME.
| Citichem India IPO | Identical Brains Studios IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Horizon Management Pvt.Ltd. | Socradamus Capital Pvt.Ltd. |
| Registrar | Kfin Technologies Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Aftertrade Broking Pvt.Ltd. | Rikhav Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Citichem India IPO is up to ₹11.96 Cr whereas the issue size of the Identical Brains Studios IPO is up to ₹18.94 Cr. The final issue price of Citichem India IPO is ₹70.00 per share and of Identical Brains Studios IPO is ₹54.00 per share.
| Citichem India IPO | Identical Brains Studios IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹51.00 per share | |
| Issue Price (Upper) | ₹54.00 per share | |
| Issue Price (Final) | ₹70.00 per share | ₹54.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 2000 shares |
| Fresh Issue Size | 17,08,000 shares | 35,08,000 shares |
| Fresh Issue Size (Amount) | up to ₹11.96 Cr | up to ₹18.94 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 17,08,000 shares | 35,08,000 shares |
| Issue Size Total (Amount) | up to ₹11.96 Cr | up to ₹18.94 Cr |
Citichem India IPO opens on Dec 27, 2024, while Identical Brains Studios IPO opens on Dec 18, 2024. The closing date of Citichem India IPO and Identical Brains Studios IPO is Dec 31, 2024, and Dec 20, 2024, respectively.
| Citichem India IPO | Identical Brains Studios IPO | |
|---|---|---|
| Anchor Bid Date | Dec 17, 2024 | |
| Issue Open | Dec 27, 2024 | Dec 18, 2024 |
| Issue Close | Dec 31, 2024 | Dec 20, 2024 |
| Basis Of Allotment (Tentative) | Jan 01, 2025 | Dec 23, 2024 |
| Initiation of Refunds (Tentative) | Jan 02, 2025 | Dec 24, 2024 |
| Credit of Share (Tentative) | Jan 02, 2025 | Dec 24, 2024 |
| Listing date (Tentative) | Jan 03, 2025 | Dec 26, 2024 |
| Anchor Lockin End date 1 | Jan 22, 2025 | |
| Anchor Lockin End date 2 | Mar 23, 2025 |
Citichem India IPO P/E ratio is 31.3, as compared to Identical Brains Studios IPO P/E ratio of 10.44.
| Citichem India IPO | Identical Brains Studios IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Citichem India Limited Financial Information (Restated)Citichem India Limited's revenue decreased by -6% and profit after tax (PAT) rose by 208% between the financial year ending with March 31, 2024 and March 31, 2023.
| Identical Brains Studios Limited Financial Information (Restated)Identical Brains Studios Limited's revenue increased by 150.71% and profit after tax (PAT) rose by 231.5% between the financial year ending with March 31, 2024 and March 31, 2023.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 83.25 | 86.53 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 61.21 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 31.3 | 10.44 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹47.60 Cr. | ₹75.74 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 15.42% | 71.66% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 21.47% | 103.52% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.15 | 0.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.24 | ₹5.17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 15.42% | 44.42% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Citichem India IPO Retail Individual Investors (RII) are offered 8,54,000 shares while in Identical Brains Studios IPO retail investors are offered 8,54,000 shares. Qualified Institutional Buyers (QIB) are offered in Citichem India IPO and 7,04,000 shares in Identical Brains Studios IPO.
| Citichem India IPO | Identical Brains Studios IPO | |
|---|---|---|
| Anchor Investor Reserveration | 10,48,000 shares | |
| Market Maker Reserveration | 92,000 shares | 1,86,000 shares |
| QIB | 7,04,000 shares | |
| NII | 8,54,000 shares | 5,28,000 shares |
| RII | 8,54,000 shares | 12,28,000 shares |
| Employee | ||
| Others | ||
| Total | 17,08,000 shares | 35,08,000 shares |
Citichem India IPO subscribed 414.35x in total, whereas Identical Brains Studios IPO subscribed 544.28x.
| Citichem India IPO | Identical Brains Studios IPO | |
|---|---|---|
| QIB (times) | 187.36x | |
| NII (times) | 277.88x | 1,020.20x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 543.18x | 544.28x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 414.35x | 544.28x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
